Cannabicyclohexanol

Cannabicyclohexanol
Legal status
Legal status	DE: Anlage II (Authorized trade only, not prescriptible); UK: Class B; US: Schedule I; Illegal in France;
Identifiers
	IUPAC name 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methylnonan-2-yl)phenol;
CAS Number	70434-92-3 ;
PubChem CID	12788231;
ChemSpider	26668381 ;
UNII	ESJ086H0VF;
KEGG	C22751;
CompTox Dashboard (EPA)	DTXSID001345227 DTXSID30875420, DTXSID001345227 ;
ECHA InfoCard	100.230.839
Chemical and physical data
Formula	C22H36O2
Molar mass	332.528 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCCCCCCC(C)(C)C1=CC(=C(C=C1)[C@@H]2CCC[C@@H](C2)O)O;
	InChI InChI=1S/C22H36O2/c1-4-5-6-7-8-14-22(2,3)18-12-13-20(21(24)16-18)17-10-9-11-19(23)15-17/h12-13,16-17,19,23-24H,4-11,14-15H2,1-3H3/t17-,19+/m1/s1 ; Key:HNMJDLVMIUDJNH-MJGOQNOKSA-N ;
	(what is this?) (verify)

Cannabicyclohexanol (CCH, CP 47,497 dimethyloctyl homologue, (C8)-CP 47,497) is a cannabinoid receptor agonist drug, developed by Pfizer in 1979. On 19 January 2009, the University of Freiburg in Germany announced that an analog of CP 47,497 was the main active ingredient in the herbal incense product Spice, specifically the 1,1-dimethyloctyl homologue of CP 47,497, which is now known as cannabicyclohexanol. The 1,1-dimethyloctyl homologue of CP 47,497 is in fact several times more potent than the parent compound, which is somewhat unexpected as the 1,1-dimethylheptyl is the most potent substituent in classical cannabinoid compounds such as HU-210.